首页> 美国卫生研究院文献>Infectious Agents and Cancer >Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1 L2 E4 E6 and E7 proteins
【2h】

Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1 L2 E4 E6 and E7 proteins

机译:通过基于变性重组HPV16 L1L2E4E6和E7蛋白的新型ELISA技术检测对人乳头瘤病毒(HPV)感染的血清抗体反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHuman papillomaviruses (HPVs) are the primary etiological agents of cervical cancer and are also involved in the development of other tumours (skin, head and neck). Serological survey of the HPV infections is important to better elucidate their natural history and to disclose antigen determinants useful for vaccine development. At present, the analysis of the HPV-specific antibodies has not diagnostic value for the viral infections, and new approaches are needed to correlate the antibody response to the disease outcome. The aim of this study is to develop a novel ELISA, based on five denatured recombinant HPV16 proteins, to be used for detection HPV-specific antibodies.
机译:背景人类乳头瘤病毒(HPV)是子宫颈癌的主要病因,也参与其他肿瘤(皮肤,头部和颈部)的发育。对HPV感染进行血清学检查对于更好地阐明其自然病史并揭示可用于疫苗开发的抗原决定簇至关重要。目前,对HPV特异性抗体的分析对病毒感染没有诊断价值,因此需要新的方法来将抗体反应与疾病结果相关联。这项研究的目的是基于五个变性的重组HPV16蛋白开发一种新型ELISA,用于检测HPV特异性抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号